Interim Report #5-Analvsis of PFBS.

AKlK> _ I07 'fi\2 m & d - k o UNITED STATES ENVIRONMENTAL PROTECTION WASHINGATGOENNDC.YC., 20460 APR %5 2 ro OFFIC " F PREVENTION, P CIDES AND TOXIC SU \NCES NOTE SUBJECT: Summary of March 7, 2001, meeting with Fluoropolymer Manufacturing Group TO: AR-226 FROM: Mary F.

/lRs*_ \!

Corporate Health Physics Corporate Industrial Hygiene & Ergonomics Corporate Occupational Medicine Corporate Toxicology 3M Medical Department 3M Center, Building 220-2E-02 PO Box 33220 ' - ' St.

, / ^P ace Analytical" j-- J Field Services Division r i i 3M1 % #1W 1 i i BACK TO MAIN PaceAnalytical Services, Inc. 1700 Elm Street, S uite 200 M inneapolis, M N 55414 Phone: 612.607.1700 Fax: 612.607.6444 Port St.

27,2000 One Generation Reproduction Study of PFOS Mevalonic Add/Cholesterol Challenge and NOEL Investigation in Rats Draft Study Outline fS -2- Study Objectives: This study will serve as a follow-up study to Combined Oral (gavagel Fertility.

0100-/37% 37i l l UNITED STATES ENVIRONMENTAL PROTECTION AGENCY S WASHINGTON, D.C. 20460 AftSiSU -OG09 July 18, 2000 fa OFFICE OF PREVENTION, PESTICIDES AND TOXIC SUBSTANCES NOTE TO FYI FILE by Terry O'Bryan/RAD/OPPT Reference: FYI-0600-01378 Submission Date: June 14, 2000 The above referenced FYI submission is 3M's response to EPA regarding three reports that appeared to be missing from their 5/4/00 submission (also FYI-01378).

/(R -- 0 6 5 If* 0B8a/r1b7a/r2a0L0e0c0z6y:n4s5kiPM cTScou::bject: Karen Lannon/DC/USEPA/US@EPA request for information on perfluorochemicals ------------------------Forwarded by Barbara Leczynski/DC/USEPA/US on 08/17/2000 06:34 PM ^ 0C4h/a1r9le/2s0A0u0e0r8:42 AM Tcco:: OgLesercacalzdry.Hnl.ksekernin/DanneCdd/eUyz@S/DEuCPsaA/U.

/)/U 3 - o?

-/} && -- iZl&O Ce: R.

Environ.

31 October 2003 To: Mary F.

/ < 79 May )<;. 2001 Christine T Whitman EPA Administrator 1101 A O'SEPA Headquarters Ariel R on Building 1200 Pennsylvania Avenue, N W Washington, D.C. 20400 RECEIVED MAY 2 3 2001 CHAIRMAN'S OFFICE Dear Ms Whitman, 1 am writing you this day to inform you o f soma criminal actions of which 1 have derailed liuTwIcri^c.

Ar s s Q> _ \ 5 & 0 SRPTT-7^1 MIN 314/022208 PERFLUOROOCTANESULFONYL FLUORIDE (POSF) -p ' BACTERIAL REVERSE MUTATION TEST Sponsor 3M Center 3M Corporate Toxicology Building 220-2E-02 St Paul MN 55133-3220 USA Research Laboratory Huntingdon Life Sciences Ltd.

ANALYTICAL METHOD VALIDATION FOR THE DETERMINATION OF PERFLUOROOCTANESULFONATE, POTASSIUM SALT (PFOS) IN ARTIFICIAL SOIL WILDLIFE INTERNATIONAL, LTD.